Maurer MJ

ORCID: 0000-0002-1867-0526 · 3 papers in corpus
2015
Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2015.01.552

ObjectiveWe demonstrate the feasibility of detecting EC by combining minimally-invasive specimen collection techniques with sensitive molecular testing.MethodsPrior to hysterectomy for EC or benign indications, women collected vaginal pool …

2015
Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers.
Oncotarget ·doi:10.18632/oncotarget.5927

Ovarian cancer represents the most lethal tumor type among malignancies of the female reproductive system. Overall survival rates remain low. In this study, we identify the serine protease inhibitor Kazal type 1 (SPINK1) as a potential ther…

2013
Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.epi-12-1368

BackgroundEpithelial ovarian cancer (EOC) is the fifth leading cause of cancer-related death in females and leading gynecologic cause of cancer-related death. Despite the identification of a number of serum biomarkers, methods to identify e…